Drug Type Small molecule drug |
Synonyms Aspirin/sumatriptan, Aspirin/sumatriptan 325/12.5 + [1] |
Target |
Action agonists, inhibitors |
Mechanism 5-HT receptor agonists(Serotonin (5-HT) receptor agonists), COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H27N3O6S |
InChIKeyPORMUFZNYQJOEI-UHFFFAOYSA-N |
CAS Registry103628-48-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Headache | Phase 2 | United States | 01 Jul 2014 |
Phase 2 | 31 | (VVD-101) | idfzdtirlq(prunetdysb) = ouucbogfvs eiglpbgwgi (frjisinyjl, fhlyufhrjf - rlrdbrapge) View more | - | 23 Mar 2017 | ||
Placebo (Placebo) | idfzdtirlq(prunetdysb) = qlpubzsbqq eiglpbgwgi (frjisinyjl, eqmqugsius - mqpvdaexsd) View more |